Pulmonary Hypertension: Expert Didactics and Discussion (Master Class)

e-Learning

This course is available for free as part of the CHEST e-Learning Library.
Access this and other e-learning activities by clicking the button below.

View e-Learning Library

Course Description

As pulmonary hypertension (PH) is a pathophysiological manifestation of many disease states, a detailed assessment is required to decide appropriate therapy. There have also been several iterations to the original definition of PH, which has led to confusion as to the correct hemodynamic threshold to initiate treatment. This Master Class clarifies issues in PH, such as proper evaluation for appropriate diagnosis, risk stratification for appropriate treatment selection, and how newer disease-modifying agents fit into current treatment algorithms.

Recorded October 5, 2024, at the CHEST 2024 Annual Meeting

Learning Objectives

Understand the pathophysiology of pulmonary arterial hypertension (PAH) and its treatment algorithms.
Assess the implications of the latest clinical trial data on current treatment strategies for PH, and integrate this knowledge into practice to enhance patient outcomes.
Interpret hemodynamics to distinguish pre- and postcapillary PH.
Understand how to diagnose and treat PH when it complicates lung disease.
Learn to manage unique complex clinical scenarios.

Presentations

Welcome and Introduction
Namita Sood, MBBS, FCCP
Understand the Pathophysiology of PAH and Treatment Algorithms
Jean Elwing, MD, FCCP
Interpret the Hemodynamics: Distinguish and Prescribe for Precapillary and Postcapillary PH
Ronald Oudiz, MD, FCCP
When PH Complicates Lung Disease: Diagnoses and Treatment
Namita Sood, MBBS, FCCP
Case Studies: Learn to Manage Unique and Complex Clinical Scenarios
Peter Leary, MD, PhD
Wrap-Up
Namita Sood, MBBS, FCCP

This activity is funded by educational grants from Merck & Co. Inc., Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson and Johnson, and United Therapeutics, a Public Benefit Company.

Publication expiration date: October 6, 2025

Item Number: 7207.96

Namita Sood, MBBS, FCCM, FCCP
Director, Advanced Lung Disease Program
University of California, Davis
Sacramento, CA

Jean Elwing, MD, FCCP
Professor of Medicine
University of Cincinnati
Cincinnati, OH

Ronald Oudiz, MD, FCCP
Chief, Division of Cardiology
Harbor - UCLA Medical Center
Torrence, CA

Peter Leary, PhD, MD
Associate Professor, Medicine – Pulmonary, Critical Care, and Sleep Medicine
University of Washington School of Public Health
Seattle, WA

CME/CE Claim Instructions
Pulmonary Hypertension: Expert Didactics and Discussion (Master Class)

To complete the CME Activity Evaluation for Pulmonary Hypertension: Expert Didactics and Discussion (Master Class), claim CME/CE credits, and download CME/CE certificates and certificates of attendance (COA), please see the instructions below. You must complete your evaluation and download your certificate prior to the product expiration date.

Sign in and navigate to your “My Learning” account at education.chestnet.org.
Find the course or event in your list, and complete all required post-course work.
Complete the course evaluation, and then claim your credits when prompted.

Note: Your certificate and transcript can be viewed at any time under Claimed Activities on the Manage CME page.

If you are claiming MOC points, please make sure that your full name, date of birth, and ABIM number listed in your CHEST account matches what is listed in your ABIM account. To prevent delays in receiving MOC points, please check that your ABIM account is current.

If you need help, contact the CHEST Help Team at helpteam@chestnet.org. For faster assistance, outline the specific problem you are having, and provide your CHEST ID and contact information.

YOU MUST COMPLETE THE POST-COURSE ASSESSMENT AND EDUCATION ACTIVITY EVALUATION PRIOR TO THE PRODUCT EXPIRATION DATE
October 6, 2025

Physician Credit

The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American College of Chest Physicians designates this enduring material for a maximum of 4.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 16433, for 4.25 contact hour.

Nurse Practitioners

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

Physician Assistants

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 4.25 Category 1 credits for completing this activity.

Maintenance of Certification Statement

Successful completion of this CME course enables the participant to earn up to 4.25 MOC Part 2 Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the course. It is the CME course provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Upon successful completion of this course, CHEST will submit your completion data to ABIM via ACCME's Program and Activity Reporting System (PARS) for MOC points. Please allow 3-5 business days after claiming for points to be reflected on your ABIM record.

DISCLAIMER

The American College of Chest Physicians (“CHEST”) and its officers, regents, executive committee members, members, related entities, employees, representatives and other agents (collectively, “CHEST Parties”) are not responsible in any capacity for, do not warrant and expressly disclaim all liability for, any content whatsoever in any CHEST publication or other product (in any medium) and the use or reliance on any such content, all such responsibility being solely that of the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any CHEST publication or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of CHEST Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.